Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
240 JPY
11.16 B JPY
75.58 B JPY
23.95 M
About KISSEI PHARMACEUTICAL CO
Sector
CEO
Mutsuo Kanzawa
Headquarters
Matsumoto
Website
Founded
1946
ISIN
JP3240600001
FIGI
BBG000BJSD42
Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. It operates through the following segments: Pharmaceuticals, Information Service, and Others. The Pharmaceuticals segment researches, develops, manufactures, and markets drugs, which are used in the fields of urology, dialysis, women's health, ophthalmology, endocrinology and metabolism. The Information Service segment offers information services to use in IT and capital investment. The Others segment includes merchandise sales and construction contractors. The company was founded on August 9, 1946 and is headquartered in Matsumoto, Japan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4547 is 4,000 JPY — it has increased by 12.52% in the past 24 hours. Watch KISSEI PHARMACEUTICAL CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange KISSEI PHARMACEUTICAL CO stocks are traded under the ticker 4547.
4547 stock has risen by 13.48% compared to the previous week, the month change is a 8.25% rise, over the last year KISSEI PHARMACEUTICAL CO has showed a 26.98% increase.
We've gathered analysts' opinions on KISSEI PHARMACEUTICAL CO future price: according to them, 4547 price has a max estimate of 4,400.00 JPY and a min estimate of 3,450.00 JPY. Watch 4547 chart and read a more detailed KISSEI PHARMACEUTICAL CO stock forecast: see what analysts think of KISSEI PHARMACEUTICAL CO and suggest that you do with its stocks.
4547 reached its all-time high on Apr 9, 2015 with the price of 3,975 JPY, and its all-time low was 1,165 JPY and was reached on Mar 15, 2011. View more price dynamics on 4547 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4547 stock is 12.36% volatile and has beta coefficient of 0.21. Track KISSEI PHARMACEUTICAL CO stock price on the chart and check out the list of the most volatile stocks — is KISSEI PHARMACEUTICAL CO there?
Yes, you can track KISSEI PHARMACEUTICAL CO financials in yearly and quarterly reports right on TradingView.
KISSEI PHARMACEUTICAL CO is going to release the next earnings report on Feb 4, 2025. Keep track of upcoming events with our Earnings Calendar.
4547 earnings for the last quarter are 25.86 JPY per share, whereas the estimation was 77.13 JPY resulting in a −66.47% surprise. The estimated earnings for the next quarter are 77.13 JPY per share. See more details about KISSEI PHARMACEUTICAL CO earnings.
4547 net income for the last quarter is 1.14 B JPY, while the quarter before that showed 4.11 B JPY of net income which accounts for −72.14% change. Track more KISSEI PHARMACEUTICAL CO financial stats to get the full picture.
KISSEI PHARMACEUTICAL CO dividend yield was 2.32% in 2023, and payout ratio reached 33.25%. The year before the numbers were 3.03% and 35.04% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has 1.78 K employees. See our rating of the largest employees — is KISSEI PHARMACEUTICAL CO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KISSEI PHARMACEUTICAL CO EBITDA is 8.27 B JPY, and current EBITDA margin is 10.94%. See more stats in KISSEI PHARMACEUTICAL CO financial statements.
Like other stocks, 4547 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KISSEI PHARMACEUTICAL CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KISSEI PHARMACEUTICAL CO technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KISSEI PHARMACEUTICAL CO stock shows the strong buy signal. See more of KISSEI PHARMACEUTICAL CO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.